|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment-where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferrari S, Smeland S, Mercuri M, Bertoni
F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini
G, et al: Neoadjuvant chemotherapy with high-dose ifosfamide,
high-dose methotrexate, cisplatin, and doxorubicin for patients
with localized osteosarcoma of the extremity: A joint study by the
Italian and Scandinavian Sarcoma Groups. J Clin Oncol.
23:8845–8852. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ragland BD, Bell WC, Lopez RR and Siegal
GP: Cytogenetics and molecular biology of osteosarcoma. Lab Invest.
82:365–373. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang H, Zeng X, Oliver P, Le LP, Chen J,
Chen L, Zhou W, Agrawal S and Zhang R: MDM2 oncogene as a target
for cancer therapy: An antisense approach. Int J Oncol. 15:653–660.
1999.PubMed/NCBI
|
|
6
|
Kushlinskii NE, Fridman MV and Braga EA:
Molecular mechanisms and microRNAs in osteosarcoma pathogenesis.
Biochemistry (Mosc). 81:315–328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li H, He Y, Hao P and Liu P:
Identification of characteristic gene modules of osteosarcoma using
bioinformatics analysis indicates the possible molecular
pathogenesis. Mol Med Rep. 15:2113–2119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shabani P, Izadpanah S, Aghebati-Maleki A,
Baghbani E, Baghbanzadeh A, Fotouhi A, Bakhshinejad B,
Aghebati-Maleki L and Baradaran B: Role of miR-142 in the
pathogenesis of osteosarcoma and its potential as therapeutic
approach. J Cell Biochem. 120:4783–4793. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lv Z, Yang D, Li J, Hu M, Luo M, Zhan X,
Song P, Liu C, Bai H, Li B, et al: Bone morphogenetic protein 9
overexpression reduces osteosarcoma cell migration and invasion.
Mol Cells. 36:119–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ren Z, Liang S, Yang J, Han X, Shan L,
Wang B, Mu T, Zhang Y, Yang X, Xiong S and Wang G: Coexpression of
CXCR4 and MMP9 predicts lung metastasis and poor prognosis in
resected osteosarcoma. Tumour Biol. 37:5089–5096. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song R, Tian K, Wang W and Wang L: P53
suppresses cell proliferation, metastasis, and angiogenesis of
osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway. Int J
Surg. 20:80–87. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rao-Bindal K, Rao CK, Yu L and Kleinerman
ES: Expression of c-FLIP in pulmonary metastases in osteosarcoma
patients and human xenografts. Pediatr Blood Cancer. 60:575–579.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Andersen GB, Knudsen A, Hager H, Hansen LL
and Tost J: miRNA profiling identifies deregulated miRNAs
associated with osteosarcoma development and time to metastasis in
two large cohorts. Mol Oncol. 12:114–131. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bilbao-Aldaiturriaga N, Gutierrez-Camino
A, Martin-Guerrero I, Pombar-Gomez M, Zalacain-Diez M,
Patiño-Garcia A, Lopez-Lopez E and Garcia-Orad A: Polymorphisms in
miRNA processing genes and their role in osteosarcoma risk. Pediatr
Blood Cancer. 62:766–769. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang R, Yan S, Wang J, Deng F, Guo Y, Li
Y, Fan M, Song Q, Liu H, Weng Y and Shi Q: MiR-30a regulates the
proliferation, migration, and invasion of human osteosarcoma by
targeting Runx2. Tumour Biol. 37:3479–3488. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lv C, Hao Y and Tu G: MicroRNA-21 promotes
proliferation, invasion and suppresses apoptosis in human
osteosarcoma line MG63 through PTEN/Akt pathway. Tumour Biol.
37:9333–9342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Namløs HM, Kresse SH, Müller CR, Henriksen
J, Holdhus R, Sæter G, Bruland OS, Bjerkehagen B, Steen VM and
Myklebost O: Global gene expression profiling of human
osteosarcomas reveals metastasis-associated chemokine pattern.
Sarcoma. 2012:6390382012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Buddingh EP, Kuijjer ML, Duim RA, Bürger
H, Agelopoulos K, Myklebost O, Serra M, Mertens F, Hogendoorn PC,
Lankester AC and Cleton-Jansen AM: Tumor-infiltrating macrophages
are associated with metastasis suppression in high-grade
osteosarcoma: A rationale for treatment with macrophage activating
agents. Clin Cancer Res. 17:2110–2119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kobayashi E, Masuda M, Nakayama R,
Ichikawa H, Satow R, Shitashige M, Honda K, Yamaguchi U, Shoji A,
Tochigi N, et al: Reduced argininosuccinate synthetase is a
predictive biomarker for the development of pulmonary metastasis in
patients with osteosarcoma. Mol Cancer Ther. 9:535–544. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fritsche-Guenther R, Noske A, Ungethüm U,
Kuban RJ, Schlag PM, Tunn PU, Karle J, Krenn V, Dietel M and Sers
C: De novo expression of EphA2 in osteosarcoma modulates activation
of the mitogenic signalling pathway. Histopathology. 57:836–850.
2011. View Article : Google Scholar
|
|
21
|
Parrish RS and Spencer HJ III: Effect of
normalization on significance testing for oligonucleotide
microarrays. J Biopharm Stat. 14:575–589. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Frigola R and Rasmussen CE: Integrated
pre-processing for bayesian nonlinear system identification with
gaussian processes. Ieee Decis Contr P. 5371–5376. 2013. View Article : Google Scholar
|
|
24
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhai X, Xue Q, Liu Q, Guo Y and Chen Z:
Colon cancer recurrenceassociated genes revealed by WGCNA
coexpression network analysis. Mol Med Rep. 16:6499–6505. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qi C, Hong L, Cheng Z and Yin Q:
Identification of metastasis-associated genes in colorectal cancer
using metaDE and survival analysis. Oncol Lett. 11:568–574. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang X, Kang DD, Shen K, Song C, Lu S,
Chang LC, Liao SG, Huo Z, Tang S, Ding Y, et al: An R package suite
for microarray meta-analysis in quality control, differentially
expressed gene analysis and pathway enrichment detection.
Bioinformatics. 28:2534–2536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang da W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang P, Wang Y, Hang B, Zou X and Mao JH:
A novel gene expression-based prognostic scoring system to predict
survival in gastric cancer. Oncotarget. 7:55343–55351.
2016.PubMed/NCBI
|
|
32
|
Jiang Q, Wang Y, Hao Y, Juan L, Teng M,
Zhang X, Li M, Wang G and Liu Y: miR2Disease: A manually curated
database for microRNA deregulation in human disease. Nucleic Acids
Res. 37:D98–D104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Betel D, Wilson M, Gabow A, Marks DS and
Sander C: The microRNA.org resource: Targets and expression.
Nucleic Acids Res 36 (Database Issue). D149–D153. 2008.
|
|
34
|
Kelly AD, Haibe-Kains B, Janeway KA, Hill
KE, Howe E, Goldsmith J, Kurek K, Perez-Atayde AR, Francoeur N, Fan
JB, et al: MicroRNA paraffin-based studies in osteosarcoma reveal
reproducible;independent prognostic profiles at 14q32. Genome Med.
5:22013. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
van Kuilenburg AB, Meinsma R, Vreken P,
Waterham HR and van Gennip AH: Identification of cDNA encoding an
isoform of human CTP synthetase. Biochim Biophys Acta.
1492:5482000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tan WL, Bhattacharya B, Loh M,
Balasubramanian I, Akram M, Dong D, Wong L, Thakkar B, Salto-Tellez
M, Soo RA, et al: Low cytosine triphosphate synthase 2 expression
renders resistance to 5-fluorouracil in colorectal cancer. Cancer
Biol Ther. 11:599–608. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Contente A, Dittmer A, Koch MC, Roth J and
Dobbelstein M: A polymorphic microsatellite that mediates induction
of PIG3 by p53. Nat Genet. 30:315–320. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Voltan R, Secchiero P, Corallini F and
Zauli G: Selective induction of TP53I3/p53-inducible gene 3 (PIG3)
in myeloid leukemic cells, but not in normal cells, by Nutlin-3.
Mol Carcinog. 53:498–504. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou H, Cui X, Yuan H, Zhang B, Meng C and
Zhao D: Effects of distinct drugs on gene transcription in an
osteosarcoma cell line. Oncol Lett. 14:4694–4700. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Smith CP, Weremowicz S, Kanai Y, Stelzner
M, Morton CC and Hediger MA: Assignment of the gene coding for the
human high-affinity glutamate transporter EAAC1 to 9p24: Potential
role in dicarboxylic aminoaciduria and neurodegenerative disorders.
Genomics. 20:335–336. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bahador R, Taheriazam A, Mirghasemi A,
Torkaman A, Shakeri M, Yahaghi E and Goudarzi PK: Tissue expression
levels of miR-29b and miR-422a in children, adolescents, and young
adults' age groups and their association with prediction of poor
prognosis in human osteosarcoma. Tumor Biol. 37:3091–3095. 2016.
View Article : Google Scholar
|
|
42
|
Liu M, Xiusheng H, Xiao X and Wang Y:
Overexpression of miR-422a inhibits cell proliferation and
invasion, and enhances chemosensitivity in osteosarcoma cells.
Oncol Rep. 36:3371–3378. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang H, He QY, Wang GC, Tong DK, Wang RK,
Ding WB, Li C, Wei Q, Ding C, Liu PZ, et al: miR-422a inhibits
osteosarcoma proliferation by targeting BCL2L2 and KRAS. Biosci
Rep. 38:BSR201703392018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Khella WZ, Bakhet M, Allo G, Jewett MA,
Girgis A, Bjarnason GA and Yousef GM: Supression of tumor
progression and metastasis in renal cell carcinoma by miR-192,
miR-194, and miR-215. J Clin Oncol. 31:385. 2013. View Article : Google Scholar
|
|
45
|
Han K, Zhao T, Chen X, Bian N, Yang T, Ma
Q, Cai C, Fan Q, Zhou Y and Ma B: microRNA-194 suppresses
osteosarcoma cell proliferation and metastasis in vitro and in vivo
by targeting CDH2 and IGF1R. Int J Oncol. 45:1437–1449. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mendes O, Kim HT and Stoica G: Expression
of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat
model. Clin Exp Metastasis. 22:237–246. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wu D, Chen K, Bai Y, Zhu X, Chen Z, Wang
C, Zhao Y and Li M: Screening of diagnostic markers for
osteosarcoma. Mol Med Rep. 10:2415–2420. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Osaki M, Takeshita F, Sugimoto Y, Kosaka
N, Yamamoto Y, Yoshioka Y, Kobayashi E, Yamada T, Kawai A, Inoue T,
et al: MicroRNA-143 regulates human osteosarcoma metastasis by
regulating matrix metalloprotease-13 expression. Mol Ther.
19:1123–1130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Senger DR, Galli SJ, Dvorak AM, Perruzzi
CA, Harvey VS and Dvorak HF: Tumor cells secrete a vascular
permeability factor that promotes accumulation of ascites fluid.
Science. 219:983–985. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Qu JT, Wang M, He HL, Tang Y and Ye XJ:
The prognostic value of elevated vascular endothelial growth factor
in patients with osteosarcoma: A meta-analysis and systemic review.
J Cancer Res Clin Oncol. 138:819–825. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang F, Tang Z, Hou X, Lennartsson J, Li
Y, Koch AW, Scotney P, Lee C, Arjunan P, Dong L, et al: VEGF-B is
dispensable for blood vessel growth but critical for their
survival, and VEGF-B targeting inhibits pathological angiogenesis.
Proc Natl Acad Sci USA. 106:6152–6157. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Abdeen A, Chou AJ, Healey JH, Khanna C,
Osborne TS, Hewitt SM, Kim M, Wang D, Moody K and Gorlick R:
Correlation between clinical outcome and growth factor pathway
expression in osteogenic sarcoma. Cancer. 115:5243–5250. 2009.
View Article : Google Scholar : PubMed/NCBI
|
